New insider activity at Cassava Sciences ( (SAVA) ) has taken place on October 2, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Chief Operating & Legal Officer Robert Christopher Cook has made a significant investment in Cassava Sciences by purchasing 13,725 shares of the company’s stock. This transaction is valued at $39,939, highlighting a strong vote of confidence in the company’s future prospects.
Recent Updates on SAVA stock
Cassava Sciences has recently released a corporate presentation as part of a Form 8-K filing, which is not considered ‘filed’ under the Securities Exchange Act of 1934. The stock has been rated as a Hold with a price target of $2.00. The company faces significant financial challenges, including no revenue and ongoing operational losses, which contribute to a low financial performance score and bearish technical indicators. A strategic license agreement with Yale University offers potential for future growth, but its impact is currently minimal due to its speculative nature. The technical sentiment signal for the stock is Sell, and it has a market cap of $104.3M.
Spark’s Take on SAVA Stock
According to Spark, TipRanks’ AI Analyst, SAVA is a Neutral.
Cassava Sciences faces significant financial challenges with no revenue and ongoing operational losses, reflected in the low financial performance score. Technical indicators show bearish trends, and the negative P/E ratio emphasizes valuation concerns. However, the strategic license agreement with Yale University could offer future growth potential, though it currently holds minimal weight due to its speculative nature.
To see Spark’s full report on SAVA stock, click here.
More about Cassava Sciences
YTD Price Performance: 16.36%
Average Trading Volume: 1,972,497
Technical Sentiment Signal: Sell
Current Market Cap: $154.6M